X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (99209) 99209
Newspaper Article (24912) 24912
Newsletter (17046) 17046
Publication (8031) 8031
Trade Publication Article (1645) 1645
Book Review (1029) 1029
Web Resource (769) 769
Magazine Article (661) 661
Book Chapter (606) 606
Book / eBook (449) 449
Conference Proceeding (286) 286
Dissertation (274) 274
Report (122) 122
Transcript (35) 35
Reference (17) 17
Government Document (11) 11
Data Set (10) 10
Paper (6) 6
Presentation (2) 2
Journal / eJournal (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cancer (55688) 55688
lung cancer (52440) 52440
oncology (51670) 51670
humans (51322) 51322
index medicus (48361) 48361
lung cancer, non-small cell (43541) 43541
research (32253) 32253
chemotherapy (26852) 26852
female (25609) 25609
care and treatment (25186) 25186
male (23932) 23932
metastasis (21874) 21874
middle aged (20512) 20512
tumors (20253) 20253
aged (19546) 19546
cancer therapies (17614) 17614
lung neoplasms - pathology (17312) 17312
oncology, experimental (16238) 16238
prognosis (15236) 15236
non-small cell lung cancer (13538) 13538
analysis (13201) 13201
adult (12993) 12993
carcinoma, non-small-cell lung - pathology (12449) 12449
genetic aspects (12413) 12413
clinical trials (12052) 12052
mutation (12006) 12006
lung cancer, small cell (11968) 11968
apoptosis (11923) 11923
lung neoplasms - drug therapy (11302) 11302
patients (10901) 10901
health aspects (10693) 10693
expression (10636) 10636
respiratory system (10413) 10413
animals (10279) 10279
survival (10214) 10214
lung neoplasms - genetics (9884) 9884
medical research (9608) 9608
carcinoma, non-small-cell lung - drug therapy (9572) 9572
proteins (9138) 9138
cell line, tumor (8990) 8990
pharmaceutical industry (8866) 8866
aged, 80 and over (8769) 8769
immunotherapy (8645) 8645
gene expression (8561) 8561
cell lung-cancer (8548) 8548
development and progression (8235) 8235
medical prognosis (8230) 8230
surgery (8227) 8227
radiotherapy (8204) 8204
neoplasm staging (8096) 8096
kinases (7886) 7886
reports (7777) 7777
carcinoma (7720) 7720
studies (7593) 7593
carcinoma, non-small-cell lung - genetics (7213) 7213
treatment outcome (7011) 7011
drug therapy (6914) 6914
epidermal growth factor (6798) 6798
adenocarcinoma (6728) 6728
lung neoplasms - metabolism (6596) 6596
hematology, oncology and palliative medicine (6540) 6540
cell biology (6461) 6461
breast-cancer (6435) 6435
lung neoplasms - mortality (6426) 6426
medicine & public health (6375) 6375
pharmacology & pharmacy (6329) 6329
breast cancer (6275) 6275
physical fitness (6230) 6230
diagnosis (6198) 6198
biomarkers (6138) 6138
medicine (5936) 5936
antineoplastic agents - therapeutic use (5632) 5632
therapy (5612) 5612
gefitinib (5558) 5558
antineoplastic agents (5532) 5532
non-small cell lung carcinoma (5345) 5345
carcinoma, non-small-cell lung - mortality (5334) 5334
retrospective studies (5268) 5268
antimitotic agents (5266) 5266
mice (5246) 5246
biochemistry & molecular biology (5195) 5195
immunohistochemistry (5134) 5134
lung-cancer (5108) 5108
nsclc (5065) 5065
article (4841) 4841
cancer research (4829) 4829
neoplasms. tumors. oncology. including cancer and carcinogens (4679) 4679
survival analysis (4647) 4647
carcinoma, non-small-cell lung - metabolism (4642) 4642
radiation therapy (4575) 4575
cisplatin (4528) 4528
antineoplastic combined chemotherapy protocols - therapeutic use (4483) 4483
patient outcomes (4470) 4470
gene expression regulation, neoplastic (4401) 4401
risk factors (4398) 4398
genes (4384) 4384
respiratory tract diseases (4320) 4320
signal transduction (4314) 4314
melanoma (4299) 4299
pathology (4292) 4292
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (235) 235
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (48) 48
Collection Dvlpm't (Acquisitions) - Vendor file (38) 38
Collection Dvlpm't (Acquisitions) - Closed Orders (21) 21
Online Resources - Online (16) 16
Gerstein Science - Circulation Desk (7) 7
Scarborough Hospital - Birchmount (7) 7
Scarborough Hospital - General (7) 7
St. Michael's Hospital - Stacks (6) 6
Humber River Regional Hospital - Finch Stacks (5) 5
Humber River Regional Hospital - Church Stacks (3) 3
Providence Healthcare - Stacks (3) 3
St Josephs Health Centre - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Credit Valley Hospital - Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Credit Valley Hospital - Special Collections (1) 1
Gerstein Science - Reference (1) 1
Lakeridge Health Sciences - Online (1) 1
Markham Stouffville Hospital - Storage (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Withdrawn (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Toronto East General Hospital - Missing (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (143303) 143303
Chinese (1359) 1359
French (474) 474
German (366) 366
Japanese (260) 260
Korean (149) 149
Spanish (124) 124
Portuguese (77) 77
Polish (64) 64
Russian (38) 38
Turkish (27) 27
Italian (17) 17
Arabic (7) 7
Czech (7) 7
Urdu (7) 7
Icelandic (4) 4
Catalan (2) 2
Dutch (2) 2
Hungarian (2) 2
Persian (2) 2
Belarusian (1) 1
Greek (1) 1
Indonesian (1) 1
Latvian (1) 1
Serbian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
ONCOTARGET, ISSN 1949-2553, 08/2017, Volume 8, Issue 32, pp. 53336 - 53351
Targeted therapies have substantially changed the management of non-small cell lung cancer (NSCLC) patients with driver oncogenes. Given the high frequency,... 
non-small cell lung cancer | RET | fusion genes | ALK | TYROSINE KINASE | FUSION GENE | OPEN-LABEL | FEATURES | CELL BIOLOGY | CELL LUNG-CANCER | caucasian population | COPY NUMBER | CRIZOTINIB | MUTATIONS | ROS1 | EXPRESSION | Life Sciences | Santé publique et épidémiologie | Biochemistry, Molecular Biology | Genomics | Cancer
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 139 - 148
Cisplatin-based adjuvant chemotherapy is the standard of care for patients with resected stage II–IIIA non-small-cell lung cancer (NSCLC). RADIANT and SELECT... 
CELL LUNG-CANCER | SURVIVAL | FORTHCOMING 7TH EDITION | 1ST-LINE TREATMENT | PLACEBO | ESMO CONSENSUS CONFERENCE | THERAPY | ONCOLOGY | TNM CLASSIFICATION | ERLOTINIB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | ErbB Receptors - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Pneumonectomy | Protein Kinase Inhibitors - adverse effects | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Young Adult | Time Factors | Vinblastine - analogs & derivatives | Vinblastine - adverse effects | China | Adult | Female | Quinazolines - administration & dosage | Chemotherapy, Adjuvant | Gefitinib | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Risk Factors | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Quinazolines - adverse effects | Cisplatin - adverse effects | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Neoplasm Staging | Vinorelbine | Lung cancer, Non-small cell | Care and treatment
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2011, Volume 129, Issue 11, pp. 2621 - 2631
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 24, pp. 2288 - 2301
The addition of atezolizumab (anti–PD-L1 antibody) to a platinum-based chemotherapy regimen improved progression-free survival among patients who had not... 
PHASE-III TRIAL | CELLS | MULTICENTER | THERAPY | BEVACIZUMAB | ANTIBODY | OPEN-LABEL | CANCER | DOCETAXEL | CHEMOTHERAPY | MEDICINE, GENERAL & INTERNAL | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - secondary | Anaplastic Lymphoma Kinase | Neoplasm Metastasis - drug therapy | Immunotherapy | Female | Paclitaxel - administration & dosage | Bevacizumab - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Carboplatin - administration & dosage | Carcinoma, Non-Small-Cell Lung - mortality | Genes, erbB-1 | B7-H1 Antigen - antagonists & inhibitors | Receptor Protein-Tyrosine Kinases - genetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Lung cancer, Non-small cell | Drug therapy | Research | Epidermal growth factor receptors | Liver | Non-small cell lung carcinoma | Oncology | Lymphocytes T | Metastasis | Cancer therapies | Patients | Bevacizumab | Metastases | Immunosuppression | Chemotherapy | Motivation | Medical prognosis | PD-L1 protein | Paclitaxel | Carboplatin | Population | Death | Vascular endothelial growth factor | Genotypes | Apoptosis | Tumors
Journal Article
Lung Cancer, ISSN 0169-5002, 2014, Volume 85, Issue 1, pp. 19 - 24
Abstract Aim Non-small cell lung cancer (NSCLC)-patients with an epidermal growth factor receptor ( EGFR )-mutation have median progression-free survival (PFS)... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | EGFR mutation | T790M-mutation | NSCLC | Targeted therapy | Rebiopsy | TKI-resistance | TRANSFORMATION | NONSMALL CELL | GEFITINIB | MECHANISM | ADENOCARCINOMA | ACQUIRED-RESISTANCE | DRUG-RESISTANCE | CELL LUNG-CANCER | TYROSINE KINASE INHIBITORS | ONCOLOGY | RESPIRATORY SYSTEM | KRAS | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Mutation, Missense | Molecular Targeted Therapy | Incidence | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacology | Retrospective Studies | Lung Neoplasms - genetics | Lung - pathology | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - diagnosis | Biopsy | Protein Kinase Inhibitors - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Adenocarcinoma - mortality | Lung cancer, Non-small cell | Genetic aspects
Journal Article